Cesarean section (CS) is an essential operative obstetric for pregnant women facing emergent conditions. It is a procedure to prevent serious maternal and perinatal complications. [@JR190046-1] Even though the World Health Organization (WHO) recommends that national CS levels should not be greater than 15% [@BR190046-2] , a multicountry survey by the WHO found that the worldwide cesarean section rates (CSRs) had increased from 26.4% in 2004 to 2008 to 31.2% in 2010 to 2011. [@JR190046-3] In Thailand, the CSR increased from 17.4% in 2000 to 2008 [@BR190046-4] to 32.7% in 2015 to 2016. [@BR190046-5]

Although CSRs have increased, maternal and perinatal mortality or morbidity rates have not been proportionately reduced in which these are essential to be monitored. [@JR190046-6] [@JR190046-7] [@JR190046-8] Postpartum hemorrhage is one of common causes of maternal death and major obstetric complications that was shown to be more common in women underwent CS than vaginal delivery. [@JR190046-6] [@JR190046-9] Similarly, birth asphyxia has been reported more common in women undergoing CS. [@JR190046-10] The information on CSR and these maternal and perinatal morbidities will be important evidences for the policy makers in individual countries to understand the CSR situation and these common maternal and perinatal morbidities.

In Thailand, there are three main public health insurance schemes, namely the Civil Servant Medical Benefit Scheme (CSMBS), Social Security Scheme (SSS), and Universal Coverage Scheme (UCS). All schemes cover the maternity services benefits. [@BR190046-11] The UCS managed by the National Health Security Office (NHSO) covers approximately three-fourths of the population (48 million). [@JR190046-12] A study showed that 96% of UCS population had completed high school or below as well as 73% were employed and the UCS adequately served the needs of beneficiaries for healthcare utilization. [@JR190046-13] Likewise, the findings from the national reproductive health survey showed high coverage of delivery by skilled birth attendance with very small socioeconomic and geographic disparities and the public sector played a majority role for maternity care. [@JR190046-14]

Approximately 50% of population under UCS in Thailand are in the poor wealth quintiles that was higher than that of the population under the CSMBS and SSS. [@JR190046-15] A study in Korea found that women with low socioeconomic status were more vulnerable to adverse maternal and perinatal outcomes including CS regardless of a universal healthcare system. [@JR190046-16] All pregnant women and their babies under the UCS receive care at public health facilities free of charge. [@JR190046-17] To get reimbursement, the health facilities have to submit data of all pregnant women under the UCS to the NHSO; therefore, the number of women giving birth and their adverse maternal and perinatal outcomes have been reocrded. [@JR190046-15] This study aimed to estimate the trend and projection of the CSR and explore the correlations between CSRs and the maternal mortality ratios (MMRs), rates of postpartum hemorrhage (PPH), neonatal mortality rates (NMRs), and birth asphyxia rates over time across all regions of Thailand.

Materials and Methods
=====================

A secondary analysis of aggregate data of CSRs, MMRs, and rates of PPH, NMRs, and rates of birth asphyxia per 1,000 live births by health region from the database of the NHSO for the years of 2009 to 2017 was performed. The data from the sections on pregnancy, childbirth and the puerperium (code O), factors influencing health status and contact with health services (code Z), and certain conditions originating in the perinatal period (code P) of the International Statistical Classification of Diseases and Related Health Problems, 10th version (ICD-10) were extracted. All in-patient data for the years 2009 to 2017 were available.

The exposure of interest in this analysis was CSR. Outcome measures were adverse maternal and perinatal outcomes including the MMRs and rates of PPH, NMRs, and rates of birth asphyxia per 1,000 live births.

CSR was calculated by dividing the number of women undergoing CS by the total number of women giving birth at all hospitals in each region of Thailand under UCS in NHSO database at the same period multiplied by 100. The number of women undergoing CS was extracted from the principle or secondary ICD-10 diagnoses of O82 or O842 and the ICD-9 740--744 or 7499 C-section procedures. Total number of women giving birth was extracted from the principle or secondary ICD-10 diagnoses of O80-O84.

MMR was calculated by dividing the number of maternal deaths by the number of live births in the same period multiplied by 100,000. Maternal death was defined as a woman who died during pregnancy, irrespective of the duration or site of the pregnancy, or within 6 weeks after termination of pregnancy from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes.

The number of maternal deaths was extracted from the principle or secondary ICD-10 diagnoses of O00-O95 or O98-O99, death on discharge status and reporting death within 30 days to the national vital registration. The number of live births was extracted from the secondary ICD-10 diagnoses of Z370, Z372, Z373, Z375, or Z376.

The rate of PPH was calculated by dividing the number of women with PPH by the total number of women giving birth in the hospitals during the same period multiplied by 100. The number of women with PPH was extracted from the principle or secondary ICD-10 diagnosis of O72.

NMR was calculated by dividing the number of live born neonates who died within 28 days of birth by the number of live births during the same period multiplied by 1,000. The number of live born neonates who died within 28 days of birth were extracted from the data of Thai Diagnosis Related Group and Death Registration.

Rate of birth asphyxia was calculated by dividing the number of live born infants with birth asphyxia using the principle or secondary ICD-10 diagnosis of P21 by the number of live births during the same period multiplied by 1,000.

Data were analyzed by R version 3.5.3 (R Foundation for Statistical Computing, Vienna, Austria, 2019). CSR and their 95% confidence intervals (CI) by health region during 2009 to 2017 were calculated. The CSR trend during 2009 to 2017 was calculated using the Joinpoint Regression Program Version 3.4.3 ( <http://surveillance.cancer.gov/joinpoint/> ). Projections of CSRs from 2018 to 2030 as the year of measurement for Sustainable Development Goals [@BR190046-18] were analyzed with the following assumptions. Same annual rate change of the data from 2009 to 2017 was used until 2020, estimated time of study findings disseminated, and followed by annual rate reductions of 0.5, 1, and 2% if any interventions have been implemented in the country. MMRs, rates of PPH, NMRs, and rates of birth asphyxia per 1,000 live births and their 95% CIs were calculated and plotted by year. Correlations between CSRs and adverse maternal and perinatal outcomes among regions of Thailand were analyzed for overall correlations and stratified by years using univariate analysis. A *p* -value less than 0.05 was considered as statistically significant.

Results
=======

The CSRs across all regions of Thailand from 2009 to 2017 are presented in [Table 1](#TB190046-1){ref-type="table"} . Annual CSR continuously increased from 23.2% in 2009 to 32.5% in 2017 ( *p* for trend \<0.001) with a 9.3% absolute increase. The average CSR through 9 years from 2009 to 2017 for each region of Thailand were significantly increased. [Figure 1](#FI190046-1){ref-type="fig"} presents the projections of CSRs from 2018 to 2030 by Joinpoint regression. With the same trend of CSR between 2009 and 2017, the CSR would be 59.1% by the year 2030. When the assumption of constant decreasing annual rates of 0.5, 1, and 2% each year are considered, CSRs of 33.9, 30.0, and 22.0% were projected by the year 2030.

###### Cesarean section rates classified by years and regions of Thailand

               Cesarean section rates (%)                                                                                                                           
  ------------ ---------------------------- -------------- -------------- -------------- -------------- -------------- -------------- -------------- -------------- ---------
  **Region**                                                                                                                                                        
   1           22.8                         22.0           23.5           24.0           24.3           25.5           26.3           28.3           29.5           \<0.001
   2           23.2                         24.6           26.8           26.8           29.3           30.7           32.3           31.2           30.5           \<0.001
   3           26.1                         25.1           28.3           28.8           30.4           33.1           34.4           35.7           35.3           \<0.001
   4           24.8                         26.1           27.1           26.7           30.2           32.0           32.7           31.5           32.4           \<0.001
   5           24.6                         24.9           26.9           27.6           29.0           31.0           32.6           32.7           33.9           \<0.001
   6           21.7                         22.2           23.9           24.2           25.2           26.5           27.2           28.2           29.0           \<0.001
   7           20.1                         21.1           23.9           24.5           27.5           29.2           31.5           32.3           34.4           \<0.001
   8           18.3                         19.0           21.3           22.4           23.8           25.4           27.3           28.0           30.0           \<0.001
   9           21.4                         21.3           23.8           25.0           27.1           27.7           30.2           30.9           32.6           \<0.001
   10          20.6                         21.9           24.6           25.1           26.6           29.5           30.3           32.7           34.4           \<0.001
   11          27.1                         26.8           29.3           31.5           32.9           35.4           37.6           36.4           37.5           \<0.001
   12          21.0                         21.0           23.2           23.2           23.5           24.4           25.5           25.7           26.7           \<0.001
   13          29.3                         29.4           31.8           34.0           35.4           38.3           40.3           39.2           36.6           0.001
                                                                                                                                                                    
   Average     23.2                         23.5           25.7           26.4           28.1           29.9           31.4           31.7           32.5           \<0.001
   (95% CI)    (21.3--25.0)                 (21.7--25.2)   (23.9--27.5)   (24.4--28.5)   (25.9--30.3)   (27.4--32.4)   (28.8--34.0)   (29.5--34.0)   (30.6--34.5)   

Abbreviation: CI, confidence interval.

![Projection of cesarean section rates (CSRs) from 2018 to 2030 by Joinpoint regression (CSRs 2009--2017---red dots; fitted and predicted line by regression---blue line; trend of CSR until 2030 projected using annual rates during 2009--2017---dashed line; and trend of CSR until 2030 projected using annual rates during 2009--2017 followed by decreasing annual rates after 2020 in different expected estimation: decreasing annual rate of 0.5%---triangle dashed line, decreasing annual rate of 1%---square dashed line, and decreasing annual rate of 2% -- diamond dashed line).](10-1055-s-0039-1697656-i190046-1){#FI190046-1}

Trends of MMR, rate of PPH, NMR, and birth asphyxia rate are shown in [Fig. 2](#FI190046-2){ref-type="fig"} . MMRs were 33 (95% CI: 22--44) per 100,000 live births in 2009 and 28 (95% CI: 18--37) per 100,000 live births in 2017 ( *p* -value for trend = 0.757). Rates of PPH increased from 2.3% (95% CI: 2.1--2.5) in 2009 to 3.1% (95% CI: 2.8--3.4) in 2017 ( *p* -value for trend \<0.001). NMRs per 1,000 live births were 5.2 (95% CI: 4.8--5.6) in 2009 and 4.4 (95% CI: 3.8--4.8) in 2009 ( *p* -value for trend \<0.001). Rates of birth asphyxia per 1,000 live births increased from 21 (95% CI: 16--27) in 2009 to 28 (95% CI: 18--39) in 2017 ( *p* -value for trend = 0.083).

![Trend of maternal mortality ratios, rates of postpartum hemorrhage, neonatal mortality rates per 1,000 live births, and rates of birth asphyxia per 1,000 live births from 2009 to 2017 (mean and 95% confidence interval).](10-1055-s-0039-1697656-i190046-2){#FI190046-2}

Increasing CSRs were significantly correlated with higher MMRs (correlation coefficient 0.20, *p* -value 0.030) and birth asphyxia rates (correlation coefficient 0.39, *p* -value \<0.001). Positive correlation between CSRs and rates of PPH (correlation coefficient 0.14, *p* -value 0.138) and negative correlation between CSRs and NMRs (correlation coefficient --0.04, *p* -value 0.788) were found but they were not significant. Correlation of CSRs with MMRs, rates of PPH, NMRs, and birth asphyxia rates by year are shown in [Figs. 3](#FI190046-3){ref-type="fig"} [4](#FI190046-4){ref-type="fig"} [5](#FI190046-5){ref-type="fig"} to [6](#FI190046-6){ref-type="fig"} . Same trends of correlation were found in the majority of year for MMRs and birth asphyxia rates when the analyses were stratified by year. Opposite direction of correlations between CSRs and rates of PPH or NMRs was found after stratifying by year when comparing with overall correlations.

![Correlation of cesarean section rates with maternal mortality ratios by year.](10-1055-s-0039-1697656-i190046-3){#FI190046-3}

![Correlation of cesarean section rates with rates of postpartum hemorrhage by year.](10-1055-s-0039-1697656-i190046-4){#FI190046-4}

![Correlation of cesarean section rates with neonatal mortality rates by year.](10-1055-s-0039-1697656-i190046-5){#FI190046-5}

![Correlation of cesarean section rates with birth asphyxia rates by year.](10-1055-s-0039-1697656-i190046-6){#FI190046-6}

Discussion
==========

One-third of pregnant women in our analysis were delivered by CS. The trend of the CSR in Thailand showed a steady increase from 2009 to 2017. If this trend continues, the CSR could reach 59.1% in 2030 if no effective interventions are implemented. To maintain the CSR of 30% or to reduce the CSR to 22% in 2030, an annual reduction rate of at least 1 to 2% is needed. The MMRs decreased during the study period but rates of PPH and birth asphyxia increased. The increasing CSRs were significantly correlated with higher MMRs and birth asphyxia rates. Overall correlation between CSRs and rates of PPH was positive but not significant.

The trend of an increasing CSR found in this study is similar to a report from a public hospital in Northern Thailand [@JR190046-19] and the findings of CS trends in 21 countries reported in a secondary analysis of two WHO multicountry surveys, except in Japan, and the national data on CSRs from 150 countries between 1990 and 2014. [@JR190046-3] [@JR190046-20] The CSRs reported in the WHO surveys (34.1% in 2004--2008 and 39.4% in 2010--2011) [@JR190046-3] were higher than the CSR in Thailand (23.5% in 2010 and 25.7% in 2011). However, the CSRs in our study were lower than those reported in Peru and Vietnam when CSRs in the same year were compared. [@JR190046-21] [@JR190046-22] This could be explained by data collected from different settings of hospitals as the WHO surveys focused mostly at the provincial levels but data of our study included all hospital levels. The high CSR rate in Vietnam was due to the study settings including both public and private facilities, which was different from our study. The CSRs in our study were similar to the CSRs reported in the Thailand Multiple Indicator Cluster Survey 2015 to 2016. [@BR190046-5]

The increasing trend of CSR in Thailand may be assumed by the reason that CS costs are covered by the health insurance plans [@JR190046-12] leading to more comfortable decision of women and doctors for delivery by CS regarding of obstetric indications. Studies on the attitudes of pregnant women during antenatal care and obstetricians & gynecologists (OB&GYN) in Thailand showed that more than 87.5% of the women and 68.9% of the OB&GYN preferred vaginal deliveries; however, one-third of the women and half of the OB&GYN agreed with women\'s request of CS. [@JR190046-23] [@JR190046-24] A review from Latin America found that the main reasons for the high CSR were obstetric procedures such as continuous fetal heart rate monitoring or induction of labor and personal perception such as better outcomes by cesarean birth, convenience of time management, or advanced maternal age. [@JR190046-25] The variation in CSR across the regions of Thailand was similar to the varying rates from different regions in Turkey, Japan, and Norway. [@JR190046-26] [@JR190046-27] [@JR190046-28]

Without any interventions or programs promoting reduction in CSR in Thailand, the projection of CSR by the end year of Sustainable Development Goals measurement would be ∼59.1%, almost double the current rate of 32.5%. A Cochrane review found the evidence on effective interventions including implementation of guidelines combined with mandatory second opinion, physician education by obstetricians, or audit, and feedback targeting at health-care professionals in reducing CSR. [@OR190046-29] A retrospective study in France found that the audit of CS situation undergone by the doctors and training of new doctors to be concerned about high CSR was associated with a reduction in CSR. [@JR190046-30]

Slightly lower MMR was shown in our analysis that was similar to the report of 2009 to 2015 WHO estimate in Thailand. [@OR190046-31] We found that CSR was positively correlated with MMR that was different from the results of a secondary analysis using data from the Demographic and Health Surveys or Multiple Indicator Cluster Surveys, in which a negative association between CSR and mortality was not significant after adjusting for the countries having CSR exceeding 10%. [@JR190046-7] Similarly, a review of maternal mortality during 1995 to 2009 in Ireland showed constant MMR along with increasing trend of CSR from 14.1% in 1995 to 26.5% in 2009. [@JR190046-32]

A significantly increasing rates of PPH was observed over time in our study, which was similar to the finding of studies from Australia and Canada, although our rate of increase was less than half the rates in those studies. [@JR190046-33] [@JR190046-34] Overall correlation of increased CSR and PPH was not significant, but the negative correlations were shown in many years. This could be explained by noting that CSR alone was not the only factor related to rate of PPH. A retrospective cohort study at one public hospital in Bangkok, the capital and largest city of Thailand, found the main risk factors for PPH were prolonged third stage of labor, retained placenta, lacerations of the birth canal, and placenta previa. [@JR190046-35] In a study from Zimbabwe, Africa, even though CS was not significantly associated with PPH, two-thirds of the women giving either vaginal birth or who underwent CS were diagnosed as PPH with estimated blood losses of 500 to 1000 mL and 1000 to 1500 mL, respectively. [@JR190046-36] Another study found that induced labor and previous CS increased the risk of severe PPH. [@JR190046-37]

NMR found in our study was somewhat higher than the point estimate value of more developed countries reported from a study using worldwide country-level data. [@JR190046-7] Although trend of NMR was slightly decreased over time, the correlations between NMRs and CSRs were mostly positive when stratified by years. This finding was similar to the findings of the 2005 WHO global survey on maternal and perinatal health in Latin America [@JR190046-8] and 2007 to 2008 in Asia in both antepartum and intrapartum CS with indications. [@JR190046-38]

Birth asphyxia rates were significantly higher in our study and correlated with increasing CSRs, which was different from the findings of a secondary analysis of two WHO surveys that found that increasing rates of CS were not significantly associated with neonatal morbidity and mortality. [@JR190046-39] An ecological study using worldwide country-level data found that a CSR higher than 10% was not associated with substantial decreases in maternal and neonatal mortality after controlling for socio-economic factors. [@JR190046-7] These differences could be explained by studies using different measurements of neonatal outcomes.

We collected data from 9 years that were statistically sufficient to determine the CSR trend over that time period. Maternal death, PPH, and birth asphyxia rates analyzed in our study are important maternal and perinatal health measures reported at international level and in Thailand. [@JR190046-6] [@JR190046-7] [@JR190046-8] [@JR190046-40]

There were some limitations of this study. First, the analysis was based on aggregate data without any demographic or clinical characteristics at individual level. Importantly, the correlations between CSR and maternal and perinatal outcomes were adjusted only by year. We therefore could not control for other potential confounding factors. A report of Ministry of Public Health, Thailand, presented that the CSR in 2007 was double in women under CSMBS compared with women under UCS. Second, the CSR projections were determined by estimating future CSR from retrospective CSR without other determinants using Joinpoint analysis. Third, the number of live births in this analysis was approximately two-thirds of all live births recorded in the national birth registration. Finally, the analysis by correlation or regression aimed to present the association of CSR with MMR, rate of PPH, NMR and birth asphyxia rate, not predicting their trends.

CSRs continuously increased during the study period in Thailand that were correlated with adverse maternal and perinatal outcomes. The increasing CS trend without any interventions aiming to reduce the CSR is alarming and requires interventions to achieve appropriate CSR. Available individual data at nation-wide scale are essential to be collected and studied along with the country strategies for reduction of rising CSRs.
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